AU4778297A - Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same - Google Patents
Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the sameInfo
- Publication number
- AU4778297A AU4778297A AU47782/97A AU4778297A AU4778297A AU 4778297 A AU4778297 A AU 4778297A AU 47782/97 A AU47782/97 A AU 47782/97A AU 4778297 A AU4778297 A AU 4778297A AU 4778297 A AU4778297 A AU 4778297A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- producing
- same
- uremic syndrome
- hemolytic uremic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention relates to the use of immunoglobulin preparations with high antibody content against EHEC hemolysin and optionally against surface antigens of EHEC hemolysin gene carrying bacteria and against shiga-like toxin II for producing an oral medicament to prevent hemolytic uremic syndrome after EHEC infection and a preparation for the same. The high antibody content can be obtained by a targeted selection of individual donors or by the immunization of donor animals.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19641466 | 1996-10-09 | ||
DE19641466A DE19641466A1 (en) | 1996-10-09 | 1996-10-09 | Oral use of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and a preparation therefor |
PCT/EP1997/005262 WO1998015578A1 (en) | 1996-10-09 | 1997-09-25 | Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4778297A true AU4778297A (en) | 1998-05-05 |
Family
ID=7808174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47782/97A Abandoned AU4778297A (en) | 1996-10-09 | 1997-09-25 | Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0941251B1 (en) |
JP (1) | JP2001502309A (en) |
AT (1) | ATE223437T1 (en) |
AU (1) | AU4778297A (en) |
DE (2) | DE19641466A1 (en) |
ES (1) | ES2183144T3 (en) |
WO (1) | WO1998015578A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10298105A (en) * | 1997-04-23 | 1998-11-10 | Gen Corp:Kk | Preventing and curing agent for infectious disease caused by enterohemorrhagic escherichia coli |
US7846435B1 (en) | 1998-05-20 | 2010-12-07 | Teijin Limited | Humanized antibodies that recognize Verotoxin II and cell line producing same |
US9579370B2 (en) | 2014-03-04 | 2017-02-28 | The Board Of Regents Of The University Of Texas System | Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination |
US10226520B2 (en) | 2014-03-04 | 2019-03-12 | The Board Of Regents Of The University Of Texa System | Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA836349B (en) * | 1982-09-02 | 1985-04-24 | Unilever Plc | Production of antibodies |
DE58904683D1 (en) * | 1988-04-19 | 1993-07-22 | Biotest Pharma Gmbh | PREPARATION WITH ANTI-CORE PERACTIVITY AND WIDE RANGE OF EFFECTS, SUBSTANCES CONTAINING OR CONTAINING THEM AND THE USE THEREOF FOR THE TREATMENT OF BACTERIAL OR TOXINE-RELATED DISEASES AND FOR THE POTENTIAL OF PROTECTION. |
WO1995008562A1 (en) * | 1993-09-20 | 1995-03-30 | Anadis Ltd. | Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
AUPN642795A0 (en) * | 1995-11-08 | 1995-11-30 | Northfield Laboratories Pty Ltd | Dairy compositions and methods of preparing same |
-
1996
- 1996-10-09 DE DE19641466A patent/DE19641466A1/en not_active Withdrawn
-
1997
- 1997-09-25 AT AT97910357T patent/ATE223437T1/en not_active IP Right Cessation
- 1997-09-25 AU AU47782/97A patent/AU4778297A/en not_active Abandoned
- 1997-09-25 DE DE59708140T patent/DE59708140D1/en not_active Expired - Lifetime
- 1997-09-25 JP JP10517131A patent/JP2001502309A/en active Pending
- 1997-09-25 WO PCT/EP1997/005262 patent/WO1998015578A1/en active IP Right Grant
- 1997-09-25 EP EP97910357A patent/EP0941251B1/en not_active Expired - Lifetime
- 1997-09-25 ES ES97910357T patent/ES2183144T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE223437T1 (en) | 2002-09-15 |
EP0941251B1 (en) | 2002-09-04 |
EP0941251A1 (en) | 1999-09-15 |
JP2001502309A (en) | 2001-02-20 |
WO1998015578A1 (en) | 1998-04-16 |
ES2183144T3 (en) | 2003-03-16 |
DE19641466A1 (en) | 1998-04-16 |
DE59708140D1 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD970199A (en) | Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati | |
AU1915995A (en) | Active immunization using a siderophore receptor protein | |
WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
MX9203832A (en) | USE OF LIPASES FOR THE PREPARATION OF MEDICINES | |
IL128014A0 (en) | Method of producing active immunity with vaccine conjugate | |
CA2145397A1 (en) | Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines | |
NZ309713A (en) | Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine | |
EP0041897A3 (en) | Polysaccharide antigen from streptococcus and vaccine containing the same | |
DK341679A (en) | VACCINE AGAINST DRAFT COOKIES AND PROCEDURES FOR PRODUCING THEREOF | |
CA2123222A1 (en) | Gram-negative bacterial vaccines | |
WO1994010317A3 (en) | Conjugate vaccine against group b streptococcus | |
IE940698L (en) | Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant | |
AU4778297A (en) | Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same | |
EP0694309A3 (en) | Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection | |
GEP20002257B (en) | Method for Reducing Fibrin Accumulation Speed, Prophylactics of Thrombus Complications and Treatment of Blood Vessels Diseases, Medicinal Composition and Medicinal Species | |
Andron LA et al. | Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis | |
EP0836480A4 (en) | Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof | |
Kurono et al. | Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeable Haemophilus influenzae in BALB/c mice | |
CA2128247A1 (en) | Vaccines based on streptokinase | |
CA2133108A1 (en) | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine | |
AU1796492A (en) | Antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof | |
AU5523196A (en) | Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms | |
AU6596390A (en) | Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes | |
Watanabe et al. | Serological analysis of supernatant liquids of cultures of El Tor vibrios | |
EP0368466A3 (en) | Compositions and methods for the treatment and prevention of gram-negative bacterial infections |